Xenon Pharmaceuticals beats market expectations despite recording third-quarter loss
XENE Xenon Pharmaceuticals Inc
$40.45 +3.27%
View chart & analysis → - 1Xenon Pharmaceuticals Inc. announced a third-quarter loss of $110.4 million on Monday.
- 2Xenon Pharmaceuticals recorded a loss of $1.11 per share in the third quarter.
- 3This result was better than the $1.14 per share loss expected by 7 analysts surveyed by Zacks Investment Research.
So what's the key point?
Xenon Pharmaceuticals reported a loss of $110.4 million in the third quarter. However, the loss was smaller than what experts had predicted.
Source Associated Press +1 · View original ↗
Today's 5 AI picks, all freeNothing hidden: past picks and how they did against the S&P 500.